ARCHIVES

FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

Breast Cancer Funding: Shalala Approves Agreement Over Disputed $14 Million

August 8, 1997

In Brief: George Vande Woude To Wistar institute Board; Donald Pinkel To Head Pediatric Leukemia Program

October 18, 1985

ASTRO Names Officers; Lane Returns To Rice Univ.

January 5, 2001

NCI contract Award

August 1, 1997

O’Connor Is New NS President, Curtiss Is Next

May 24, 1991

Emerging Technologies: Company To Expand Program Studying Polymer Platinates

June 1, 2001